Support

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (5191)

Sunday, 08 August 2021 11:19

Filippo Lococo

Written by
Sunday, 08 August 2021 11:19

Dania Nachira

Written by
Sunday, 08 August 2021 11:19

Vittorio Aprile

Written by
Sunday, 08 August 2021 11:19

Pietro Bertoglio

Written by
Dr. Bertoglio is staff surgeon at the University Hospital of Bologna, Italy. He is a member of the IASLC Staging and Prognostic Factors Committee, and an active member of EACTS and ESTS. His clinical, surgical and research interest is mainly focused on lung cancer multimodal treatment and malignant pleural mesothelioma.
Sunday, 08 August 2021 11:19

William Travis

Written by
Sunday, 08 August 2021 11:19

Prasad Adusumilli

Written by
I am the Deputy Chief and Attending thoracic surgeon at the Memorial Sloan Kettering Cancer Center, New York with expertise in the management of cancers in the chest. As Vice Chair in the Dept. of Surgery, my goal is to develop translational research for solid tumors.
My laboratory research, supported by NIH RO1 and DoD awards, focuses on tumor immunology, and chimeric antigen receptor (CAR) T-cell-mediated immunotherapy for cancers. Over the years, we have developed clinically-relevant solid tumor mouse models and modeled regional delivery of novel biological therapies including oncolytic viruses and immune cells in these models. This research has yielded mechanistic data that has been translated and is now in clinical trials. As Director of the mesothelioma program, I oversee ongoing clinical research efforts on combination immunotherapy to reactivate both CAR T-cell and endogenous immunity by use of cell-intrinsic and extrinsic checkpoint blockade strategies; combination of CAR T cells with anti-PD1 agent is now in phase II clinical trial. As Head of solid tumor cell therapy in the Cellular Therapeutics Center at the Memorial Sloan Kettering (MSK) Cancer Center, I conduct and coordinate cell therapy clinical trials for solid tumor patients.
Sunday, 08 August 2021 11:19

Natasha Rekhtman

Written by
Page 204 of 371